Navigation Links
Data Monitoring Committee Unanimously Recommends Continuation of Celsion's Phase III ThermoDox® HEAT Study to Treat Primary Liver Cancer
Date:9/30/2010

validity of the trial design.  The trial design and statistical plan for the HEAT study also incorporates a pre-planned interim efficacy analysis by the DMC (after patient enrollment is complete and 190 progression-free survival events are realized in the study population) with the intent of evaluating safety and efficacy results to determine if there is overwhelming evidence of clinical benefit or a low probability of treatment success (a futility analysis) to continue, modify or terminate the trial.

"We are very pleased that the DMC has unanimously recommended continuation of the HEAT study based on its review of all available clinical data, both safety and efficacy, in over 400 patients," stated Mr. Michael H. Tardugno, Celsion's President and Chief Executive Officer.  "The DMC's affirmative review is further evidence of ThermoDox's potential to provide a first line of chemotherapy for the treatment of primary liver cancer."

The National Institutes of Health and regulatory agencies around the world as well as the liver cancer medical community have all recognized the potential of ThermoDox for the treatment of this unmet medical need as evidenced by the following:

  • HEAT study is being conducted under a Special Protocol Assessment with the FDA;
  • HEAT study has been granted a Fast Track Designation by the FDA; and
  • The National Cancer Institute's recent designation of the HEAT study as a Priority Clinical Trial at its recent Clinical Trial Planning Meeting for HCC.

  • About Primary Liver CancerPrimary liver cancer is one of the most deadly forms of cancer and ranks as the fifth most common solid tumor cancer.  The incidence of primary liver cancer is approximately 20,000 cases per year in the United States and has a worldwide incidence of approximately 650,000 cases, due to the high prevalence of Hepatitis B and C in developing countries.  The standard first line treatment for liver cancer is surgi
    '/>"/>

    SOURCE Celsion Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. ACC Concerned Over Reporting of Biomonitoring Results
    2. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
    3. FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
    4. Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
    5. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
    6. Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
    7. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
    8. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
    9. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
    10. eRT Announces the Availability of the Suicidality Monitoring System(TM) For Clinical Trials
    11. Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... SAN DIEGO , Aug. 29, 2014 /PRNewswire/ ... an emerging biopharmaceutical company, announced today that Santosh ... will be leaving the Company, for personal reasons, ... the Chief Medical Officer of Aires Pharmaceuticals, which ... Vetticaden,s former responsibilities as the Company,s interim Chief ...
    (Date:8/29/2014)... , Aug. 29, 2014  BC Technical, the ... acquired Polaris Medical Imaging, a leader in sales, service ... strategic acquisition allows BC Technical to continue to expand ... within MR and CT modalities. "We ... said Mark Alvarez , president and CEO of ...
    (Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
    Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4BC Technical Acquires Polaris Medical Imaging 2US CNS Disorders Drug Pipeline Insight 2014 2
    ... 2010 General-use X-ray security systems are one ... to widespread use to check people entering secured ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... the low risk to health associated with these ...
    ... N.Y., Nov. 4, 2010 At a special meeting today, ... approve the merger of West Acquisition Corp., an indirect wholly ... ), with and into Penwest and voted to approve the ... Penwest, West and Endo.   The merger became ...
    Cached Medicine Technology:
    (Date:8/31/2014)... August 31, 2014 The severity of ... provider specializing in menopause is expert in helping ... and relief from uncomfortable symptoms with the latest treatment ... therapies offer a variety of alternative treatments and products ... these treatment options may fall outside of what can ...
    (Date:8/31/2014)... Sunday 31 August 2014: Drinking tea reduces non-cardiovascular ... people presented at ESC Congress today by Professor Nicolas ... have to choose between tea or coffee it,s probably ... components of our way of life. Their effects on ... with sometimes divergent results. We investigated the effects of ...
    (Date:8/30/2014)... Spain Sunday 31 August 2014: Local anaesthetic is ... (TAVI) as general anaesthetic, according to results of the ... Dr Romain Chopard from France. , Dr Chopard said: ... treatment alternative for patients with severe symptomatic aortic stenosis ... conventional surgical aortic valve replacement. The number of TAVI ...
    (Date:8/30/2014)... Orlando, Florida (PRWEB) August 31, 2014 ... gait walking and how a mobility device can help in ... now available for free download from the website that contains ... medical doctor for this site. , The articles deal with ... mobility device like a walking cane can help in making ...
    (Date:8/30/2014)... In a world where a typical response ... Group, LLC launches a game app to teach another way. ... Ultimate Karma app is a colorful way to encourage moral ... the game pulls double-duty by teaching players new ways to ... to reward gamers for consistently taking the high road, the ...
    Breaking Medicine News(10 mins):Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 2Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 4Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 5Health News:Drinking tea reduces non-CV mortality by 24 percent 2Health News:Drinking tea reduces non-CV mortality by 24 percent 3Health News:Local anesthetic for TAVI as safe and effective as general anesthetic 2Health News:Information Articles on Gait Problems from Walking-Canes.Net 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2
    ... , SATURDAY, June 20 (HealthDay News) -- Mowing the ... people forget that their lawn mower can cause serious ... States, about 200,000 people (including 16,000 children) are injured ... Product Safety Commission. Those injuries include severed fingers, toes ...
    ... 600 Kidney-Friendly Recipes to Meet Kidney Care Needs for Dads ... Inc. (NYSE: DVA ), a leading provider of ... (CKD), offers fathers and their families the opportunity to enjoy ... 600 kidney-friendly recipes available on DaVita.com . ...
    ... U.S. Senator Amy Klobuchar to visit Healthy Athletes Village and ... Today is the last day to catch Summer Games action ... Klobuchar will visit Healthy Athletes Village today from 9:30-10 a.m. ... from 10-10:30 a.m. at Bierman Field. , , Healthy ...
    ... imaging equipment is in use in outpatient settings does ... Payment Advisory Commission (MedPAC) recommend Medicare utilize to calculate ... the Radiology Business Management Association (RBMA), a national association ... data, which consist of 261 imaging machines in 46 ...
    ... , SEATTLE, June 19 /PRNewswire-FirstCall/ -- ... CTIC) today announced the final results of its separate concurrent ... the "Exchange Offers") for any and all of the approximately ... convertible notes (the "Notes"). The Exchange Offers expired at ...
    ... As President Obama prepares to sign a bill giving ... tobacco industry, a new study from Harvard School of ... continually changed the ingredients and the design of their ... acceptable product variance guidelines. The result, say the researchers, ...
    Cached Medicine News:Health News:Don't Get Lazy About Lawn-Mower Safety 2Health News:DaVita.com Provides Easy Recipes to Plan Your Father's Day Dinner 2Health News:DaVita.com Provides Easy Recipes to Plan Your Father's Day Dinner 3Health News:Last Day of Special Olympics Minnesota's 2009 Summer Games 2Health News:Last Day of Special Olympics Minnesota's 2009 Summer Games 3Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 2Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 3Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 4Health News:Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 2Health News:Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 3Health News:Study finds that tobacco companies changed design of cigarettes without alerting smokers 2
    ... in the field of point of diagnostics pathology, ... a back-up instrument in routine pathology laboratories. With ... for the cover, the CM1100 can be transported ... transformer, it can be run on a car ...
    ... The OTF5000 represents the new ... the long-established and reliable OTF/AS cryostat, ... blade systems in the ever-reliable and ... of options plus money-saving package deals ...
    ... The HM 560 Cryo-Star - ... have been incorporated which offer the ... electronic, optionally motorized cryostat with retraction ... for independent specimen and knife cooling. ...
    ... new tissue infiltration instrument, which combines well-proven ... The robust caroussel design is proven and ... instrument includes either 10 reagent and 2 ... paraffin containers. Up to 10 different programs ...
    Medicine Products: